https://www.selleckchem.com/pr....oducts/dibutyryl-cam
0%); could be used on the face and ears (83.5% vs 45.4%); and could be self-administered at home (83.5 vs 45.4%). Interestingly, more than half of them were uncertain about its long-term effects and adverse reactions. This study confirms the facial candling use among patients with AR although the percentage is low. The patients and general public need to be better informed about the use of facial candling in AR and its associated risks. This study confirms the facial candling use among patients with AR although the pe
Like
Comment
Share
